Frequent Copy Number Gain of MCL1 as a Therapeutic Target for Osteosarcoma

Frequent Copy Number Gain of MCL1 as a Therapeutic Target for Osteosarcoma

Academic Research Report: MCL1 Copy Number Gain as a Therapeutic Target for Osteosarcoma Academic Background Osteosarcoma (OS) is a primary malignant bone tumor that predominantly affects children and adolescents. Although the treatment regimen combining surgery with chemotherapy was established in the 1970s and remains the standard therapy, progre...